Science, Not Narrative – MWGFD Confronts EMA with Facts - MWGFD
veröffentlicht am 23. 07. 2026 von Team RedaktionAs part of Dr. Silvia Behrendt’sTransparency4Safety Initiative(MWGFD sent a letter to the EMA on 28 April 2026, which we make available below in. . .
veröffentlicht am 23. 07. 2026 von Team RedaktionAs part of Dr. Silvia Behrendt’sTransparency4Safety Initiative(MWGFD sent a letter to the EMA on 28 April 2026, which we make available below in bothGermanandEnglish. We reported on this in April 2026 inthis article. In herreplydated 29 June 2026, Ms. Cooke addressed our request for an in-person meeting under point 3 as follows:„As already notified to GHRA, EMA will not discuss, in the context of said meeting, scientific matters regarding the concerned mRNA COVID-19 vaccines. Further, the Agency will hold the meeting in person only, at its premises in Amsterdam, and it will not be livestreamed. “The requested meeting took place on 2 July 2026 in a small setting in Amsterdam with the two lawyers Dr. Silvia Behrendt and Dr. Jasper Bovenberg. Dr. Silvia Behrendt reports on the meeting inthis Substack article. Regarding the safety of the COVID-19 vaccines, Ms. Cooke wrote under point 2 that„[…] we would like to underscore that, to date, EMA has not seen any reliable scientific data demonstrating safety concerns capable of overturning the current positive risk-benefit balance for Comirnaty and Spikevax. “In response, MWGFD considered it necessary to challenge Ms. Cooke’s statement above. In a further letter, we present our position supported by scientific evidence. We make this letter available below in both English and German. Bildquelle: erstellt mit KI-UnterstützungSchlagwörterCOVID-Impfstoff,EMA,transparency4safety